AstraZeneca plc (AZN) stock is higher by 28.69% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives AZN stock a score of 82 out of a possible 100.
That rank is chiefly influenced by a short-term technical score of 91. AZN's rank also includes a long-term technical score of 88. The fundamental score for AZN is 68. In addition to the average rating from Wall Street analysts, AZN stock has a mean target price of 58.525. This means analysts expect the stock to climb 10.95% over the next 12 months.
What's Happening with AZN Stock Today
AstraZeneca plc (AZN) stock is down -0.49% while the S&P 500 is lower by -1.92% as of 11:31 AM on Friday, Jun 26. AZN is lower by -$0.26 from the previous closing price of $53.01 on volume of 2,255,744 shares. Over the past year the S&P 500 is up 3.40% while AZN is higher by 28.69%. AZN earned $0.58 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 90.68.
Click Here to get the full Stock Score Report on AstraZeneca plc (AZN) Stock.
